The mission of the Tufts
Health Care Institute Program on Opioid Risk Management is to address challenges
in the development and utilization of opioid analgesics, by engaging a multidisciplinary
group of stakeholders focused on optimizing the benefits of opioid for pain management,
and minimizing their risks, including abuse and diversion.
March 10-11, 2011
Improving opioid prescribing in the 21st century
Nathaniel Katz, MD, MS Presentation >>
The vision of implementation science and how it can impact physician behavior
James Dearing, PhD Presentation >>
Steps of implementation science and how they apply to safe opioid prescribing: Pre-implementation
Shannon Wiltsey-Stirman, PhD Presentation >>
Redesign and implementation
Lisa Zubkoff, PhD Presentation >>
Evaluation
Jodie Trafton, PhD Presentation >>
Real life experience with systems change to improve opioid safety:
Operation Unite
Karen Kelly Presentation >>
VA pain care agreements
Rosemary Mehl, MD Presentation >>
NY tamper resistant prescription pad program
Jim Giglio Presentation >>
Utah academic detailing program
Susan Cochella, MD Presentation >>
New Hampshire safe prescribing initiative
Seddon Savage, MD Presentation >>
Lessons learned from SBIRT
Daniel Alford, MD, MPH Presentation >>
Study of treatment for patients at risk for prescription opioid abuse
Ajay Wasan, MD, MSc Presentation >>
Mass. Naloxone distribution program
Alexander Walley, MD Presentation >>
Overview of computer-based training
Gwen Murphy RD, PhD Presentation >>
Effectiveness of simulation-based training: the evidence-base and measurement of outcomes
Lewis Johnson, PhD Presentation >>
Application of simulation-based training in the medical field
Benjamin Lok, PhD Presentation >>
Lessons learned from marketing on prescriber behavior change
Edward Heimers, Jr. Presentation >>
Funding for this program was made possible (in part) by (PA-08-149) from the National Institute on Drug Abuse. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
|